ProPhase Labs (NASDAQ:PRPH) Upgraded by Zacks Investment Research to Buy

ProPhase Labs stock has undergone multiple analysts rating changes in the recent past.  ProPhase Labs Upgraded by Zacks Investment Research on 10/14/2021. In a note to investors, the firm issued a new rating of Buy. The analysts previously had rating of Strong Sell.

Shares of ProPhase Labs traded down -$0.08 on Wednesday, reaching $5.34. 0 shares of the stock traded hands, compared to its average volume of 49123. Shares of ProPhase Labs were trading at $5.34 on Wednesday. The firm’s 50 day moving average is $5.57 and its 200 day moving average is $6.99.ProPhase Labs has a 12 month low of $5.09 and a 12 month high of $16.04. While on yearly highs and lows, ProPhase Labs’s today has traded high as $5.48 and has touched $5.09 on the downward trend. See More Analyst Rating at: RATING

ProPhase Labs Earnings and What to expect: 

ProPhase Labs last released its earnings data on August 12th, 2021. The reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.19 by $0.28. The firm had revenue of $9.14 million for the quarter, compared to the consensus estimate of $14.64 million. ProPhase Labs has generated ($0.20) earnings per share over the last year. Earnings for ProPhase Labs are expected to grow by 8.11% in the coming year, from $0.74 to $0.80 per share. ProPhase Labs has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 15th, 2021 based off prior year’s report dates.

Earnings for ProPhase Labs are expected to grow by 8.11% in the coming year, from $0.74 to $0.80 per share. The P/E ratio of ProPhase Labs is -26.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of ProPhase Labs is -26.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. ProPhase Labs has a P/B Ratio of 7.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

ProPhase Labs (NASDAQ:PRPH) Moving Average Technical Analysis

5 day Moving Average is $5.39 And 5 day price change is -$0.02 (-0.37%)  with average volume for 5 day average is 27,640. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $5.19 and 20 day price change is $0.39 (7.88%) and average 20 day moving volume is 38,970. 50 day moving average is $5.57  and 50 day price change is -$1.89 ( -26.14%)  and with average volume for 50 days is : 79,228. 200 day moving average is $6.99  and 200 day price change is -$5.63 (-51.32%)  and with average volume for 200 days is : 261,197.

Other owners latest trading in ProPhase Labs :

  • On 8/17/2021 shares held by Millennium Management LLC were 46,575 which equates to market value of $0.29M and appx 0.00% owners of ProPhase Labs
  • On 8/16/2021 shares held by Bank of America Corp DE were 28,600 which equates to market value of $0.18M and appx 0.00% owners of ProPhase Labs
  • On 8/16/2021 shares held by State Street Corp were 13,795 which equates to market value of $86K and appx 0.00% owners of ProPhase Labs
  • In total Institutional ownership equates to Institutional Ownership Percentage: 10.59% for ProPhase Labs

See More Analyst Rating at: RATING